You are here

Biocure Technology Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
CURE
CSE Index: 
Currency: 

 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

You are here

Biocure Technology Inc. (CURE)

SEDAR Information

Biocure Technology Inc.
Date: September 4, 2018
Biocure Technology Inc.
Date: July 19, 2018
Biocure Technology Inc.
Date: July 5, 2018
Biocure Technology Inc.
Date: June 21, 2018
Biocure Technology Inc.
Date: June 15, 2018
Biocure Technology Inc.
Date: May 31, 2018
Biocure Technology Inc.
Date: May 8, 2018
Biocure Technology Inc.
Date: April 16, 2018
Biocure Technology Inc.
Date: April 2, 2018
Biocure Technology Inc.
Date: March 1, 2018
Biocure Technology Inc.
Date: February 20, 2018
Biocure Technology Inc.
Date: February 15, 2018
Biocure Technology Inc.
Date: February 8, 2018
Biocure Technology Inc.
Date: January 31, 2018
Biocure Technology Inc.
Date: December 18, 2017
Biocure Technology Inc.
Date: December 5, 2017
Biocure Technology Inc.
Date: December 4, 2017
Biocure Technology Inc.
Date: November 27, 2017
Biocure Technology Inc.
Date: November 23, 2017
Biocure Technology Inc.
Date: August 30, 2017
Biocure Technology Inc.
Date: June 21, 2017
Biocure Technology Inc.
Date: March 22, 2017
Biocure Technology Inc.
Date: October 28, 2016
Biocure Technology Inc.
Date: August 28, 2015
Biocure Technology Inc.
Date: January 16, 2015

Company Info

Address
300-1055 West Hastings Street
Vancouver, BC V6E 2E9
Canada
Phone
604-609-7146
Fax
N/A
Email
admin@biocuretech.com
Website
http://www.biocuretech.com
Listing date
Monday, May 10, 2010
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
n/a
Auditor
DMCL Chartered Professional Accountants

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
96,793,301
Reserved for Issuance: 

Bulletins

28/11/2017

2017-1117 – Fundamental Change – Gravis Energy Corp./Biocure Technology Inc.

le 28 novembre/November 2017

Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.

Listing and disclosure documents will be available at thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

10_17_JOURNEY_2018_Website

JOURNEY 2018

Wednesday, October 17, 2018 (All day)
XPLOR_2018

XPLOR 2018

Wednesday, October 17, 2018 (All day) to Thursday, October 18, 2018 (All day)